Industry prescribes weight-loss drugs to anorexia patients

A rise in the use of GLP-1 weight-loss drugs through telehealth platforms has raised concerns about safety and access, especially among individuals with anorexia. Many patients, including those with eating disorders, can obtain these medications easily online without proper medical evaluation, leading to potentially dangerous outcomes. Experts warn that lax prescribing practices and the widespread availability of these drugs complicate treatment efforts and pose risks to vulnerable populations.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل